New artificial intelligence tools used in healthcare could face a temporary “L-plates” approval system under recommendations from a major UK review of AI regulation.

The proposed approach would allow promising AI healthcare technologies to be introduced into real-world settings while requiring developers and regulators to closely monitor their safety and effectiveness after deployment.

The review, led by the National Commission into the Regulation of AI in Healthcare, gathered views from around 12,000 patients, clinicians and technology developers. It calls for stronger monitoring of AI systems after approval and greater public access to information about safety incidents.

The recommendations also include stronger enforcement powers for the Medicines and Healthcare products Regulatory Agency (MHRA) and greater transparency when AI is used in patient care.

The proposals highlight the challenge facing Britain as healthcare providers increasingly explore AI for diagnosis, treatment and clinical decision-making. Regulators want to encourage technology innovation without compromising patient safety.